AGP Picks
View all

Health Press Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Bhutan.

Press releases published on October 21, 2026

PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026
Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026
Collegium to Present Pediatric and Real-World Research Across ADHD Portfolio at AACAP and NEI Fall Congresses
Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026
Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
Arbor Biotechnologies Nominates Three Gene Editing Development Candidates for ALS, with Potential to Address Up to 97% of People Living with the Disease
Apyx Medical Corporation to Participate in Upcoming Investor Conferences
Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time
electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub
Jyong Biotech to Host Two-Day Investor Events in Silicon Valley and Irvine, California
Cellyan Biotechnology Announces a 1-for-20 Reverse Stock Split
Hyro’s new brand identity champions Agentic Care Communications, rallying the healthcare industry around delivering Care OnCue™
Eyonis Invited to Present AI Advances in Lung Cancer Detection and Diagnosis at 50th I-ELCAP Conference
Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ™ 
Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto
INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027
Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026
Sitryx to Participate in Upcoming Investor Conferences

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Press Bhutan

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.